A clinician’s guide for navigating the world of attention deficit hyperactivity disorder medications. Mattingly, G. W. & Young, J. CNS Spectrums, 26(2):104–114, April, 2021. ![A clinician’s guide for navigating the world of attention deficit hyperactivity disorder medications [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex Once considered a condition of hyperactive boys, our knowledge and understanding of attention deficit hyperactivity disorder (ADHD) and has dramatically evolved. 1 Landmark studies by Biederman, Kessler, Faraone, and others have changed and deepened our understanding of ADHD to include a condition which not only affects boys but quite often affects girls. 1–5 The evolution of symptoms across the lifespan and the concomitant neurologic changes which underlie this symptomatic expression has similarly evolved. 6 Studies by Dalsgaard and others have brought to light the significantly increased morbidity and mortality associated with preschoolers, children, and adults struggling with ADHD and associated conditions. 7,8
@article{mattingly_clinicians_2021,
title = {A clinician’s guide for navigating the world of attention deficit hyperactivity disorder medications},
volume = {26},
issn = {1092-8529, 2165-6509},
url = {https://www.cambridge.org/core/product/identifier/S1092852921000146/type/journal_article},
doi = {10.1017/S1092852921000146},
abstract = {Once considered a condition of hyperactive boys, our knowledge and understanding of attention deficit hyperactivity disorder (ADHD) and has dramatically evolved.
1
Landmark studies by Biederman, Kessler, Faraone, and others have changed and deepened our understanding of ADHD to include a condition which not only affects boys but quite often affects girls.
1–5
The evolution of symptoms across the lifespan and the concomitant neurologic changes which underlie this symptomatic expression has similarly evolved.
6
Studies by Dalsgaard and others have brought to light the significantly increased morbidity and mortality associated with preschoolers, children, and adults struggling with ADHD and associated conditions.
7,8},
language = {en},
number = {2},
urldate = {2023-05-30},
journal = {CNS Spectrums},
author = {Mattingly, Gregory W. and Young, Joel},
month = apr,
year = {2021},
pages = {104--114},
}
Downloads: 0
{"_id":"aLT4n8AJSXCXDydfn","bibbaseid":"mattingly-young-acliniciansguidefornavigatingtheworldofattentiondeficithyperactivitydisordermedications-2021","author_short":["Mattingly, G. W.","Young, J."],"bibdata":{"bibtype":"article","type":"article","title":"A clinician’s guide for navigating the world of attention deficit hyperactivity disorder medications","volume":"26","issn":"1092-8529, 2165-6509","url":"https://www.cambridge.org/core/product/identifier/S1092852921000146/type/journal_article","doi":"10.1017/S1092852921000146","abstract":"Once considered a condition of hyperactive boys, our knowledge and understanding of attention deficit hyperactivity disorder (ADHD) and has dramatically evolved. 1 Landmark studies by Biederman, Kessler, Faraone, and others have changed and deepened our understanding of ADHD to include a condition which not only affects boys but quite often affects girls. 1–5 The evolution of symptoms across the lifespan and the concomitant neurologic changes which underlie this symptomatic expression has similarly evolved. 6 Studies by Dalsgaard and others have brought to light the significantly increased morbidity and mortality associated with preschoolers, children, and adults struggling with ADHD and associated conditions. 7,8","language":"en","number":"2","urldate":"2023-05-30","journal":"CNS Spectrums","author":[{"propositions":[],"lastnames":["Mattingly"],"firstnames":["Gregory","W."],"suffixes":[]},{"propositions":[],"lastnames":["Young"],"firstnames":["Joel"],"suffixes":[]}],"month":"April","year":"2021","pages":"104–114","bibtex":"@article{mattingly_clinicians_2021,\n\ttitle = {A clinician’s guide for navigating the world of attention deficit hyperactivity disorder medications},\n\tvolume = {26},\n\tissn = {1092-8529, 2165-6509},\n\turl = {https://www.cambridge.org/core/product/identifier/S1092852921000146/type/journal_article},\n\tdoi = {10.1017/S1092852921000146},\n\tabstract = {Once considered a condition of hyperactive boys, our knowledge and understanding of attention deficit hyperactivity disorder (ADHD) and has dramatically evolved.\n 1\n Landmark studies by Biederman, Kessler, Faraone, and others have changed and deepened our understanding of ADHD to include a condition which not only affects boys but quite often affects girls.\n 1–5\n The evolution of symptoms across the lifespan and the concomitant neurologic changes which underlie this symptomatic expression has similarly evolved.\n 6\n Studies by Dalsgaard and others have brought to light the significantly increased morbidity and mortality associated with preschoolers, children, and adults struggling with ADHD and associated conditions.\n 7,8},\n\tlanguage = {en},\n\tnumber = {2},\n\turldate = {2023-05-30},\n\tjournal = {CNS Spectrums},\n\tauthor = {Mattingly, Gregory W. and Young, Joel},\n\tmonth = apr,\n\tyear = {2021},\n\tpages = {104--114},\n}\n\n","author_short":["Mattingly, G. W.","Young, J."],"key":"mattingly_clinicians_2021","id":"mattingly_clinicians_2021","bibbaseid":"mattingly-young-acliniciansguidefornavigatingtheworldofattentiondeficithyperactivitydisordermedications-2021","role":"author","urls":{"Paper":"https://www.cambridge.org/core/product/identifier/S1092852921000146/type/journal_article"},"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/tub49573","dataSources":["zdB47AZpEkG3LzPTn"],"keywords":[],"search_terms":["clinician","guide","navigating","world","attention","deficit","hyperactivity","disorder","medications","mattingly","young"],"title":"A clinician’s guide for navigating the world of attention deficit hyperactivity disorder medications","year":2021}